ABBVIE INC (ABBV)

US00287Y1091 - Common Stock

136.465  +3.03 (+2.27%)

ABBVIE INC

NYSE:ABBV (6/2/2023, 1:42:08 PM)

136.465

+3.03 (+2.27%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)04-27 2023-04-27/bmo
Earnings (Next)07-27 2023-07-27/bmo
Ins Owners0.1%
Inst Owners68.28%
Market Cap240.76B
Shares1.76B
PE10.43
Fwd PE12.05
Dividend Yield4.27%
Analysts73.53
IPO01-02 2013-01-02
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABBV Daily chart

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. The company offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.

Company Info

ABBVIE INC

1 N Waukegan Rd

North Chicago ILLINOIS 60064

P: 18479327900.0

CEO: Richard A. Gonzalez

Employees: 50000

Website: https://www.abbvie.com/

ABBV News

News Image2 hours ago - Investor's Business DailyThe Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

News Imagea day ago - The Motley Fool7 Best Dividend Stocks to Buy Now in June 2023

These top dividend stocks are attractive at these levels and lower, and they add excellent diversity to a long-term investing portfolio.

News Imagea day ago - ChartmillStay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

News Imagea day ago - Market News VideoNotable Thursday Option Activity: AMGN, ABBV, RCL
News Imagea day ago - ChartmillUnusual volume S&P500 stocks in Thursday's session

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

News Imagea day ago - The Motley FoolWhy AbbVie and Amgen Are Moving Lower Today

An ultra-low-priced biosimilar may negatively impact both biotechs.

ABBV Twits

Here you can normally see the latest stock twits on ABBV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example